Is Spectrum Pharmaceuticals, Inc. (SPPI) the Top Pick in the Biotechnology Industry? – InvestorsObserver

A rating of 64 puts Spectrum Pharmaceuticals, Inc. (SPPI) near the middle of the Biotechnology industry according to InvestorsObserver. Spectrum Pharmaceuticals, Inc.'s score of 64 means it scores higher than 64% of stocks in the industry. Spectrum Pharmaceuticals, Inc. also received an overall rating of 54, putting it above 54% of all stocks. Biotechnology is ranked 32 out of the 148 industries.

Finding the best stocks can be tricky. It isnt easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObservers tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObservers overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. Theres no need to try to remember what is good for a bunch of complicated ratios, just pay attention to which numbers are the highest.

Spectrum Pharmaceuticals, Inc. (SPPI) stock is lower by -9.18% while the S&P 500 is higher by 0.46% as of 9:56 AM on Wednesday, Dec 23. SPPI is down -$0.39 from the previous closing price of $4.25 on volume of 501,103 shares. Over the past year the S&P 500 is higher by 14.92% while SPPI is down -55.89%. SPPI lost -$1.37 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Spectrum Pharmaceuticals, Inc. (SPPI) Stock.

Read the original:
Is Spectrum Pharmaceuticals, Inc. (SPPI) the Top Pick in the Biotechnology Industry? - InvestorsObserver